v1
215 First-in-man study evaluating the safety, tolerability, pharmacokinetics and concentrationQT analysis of the novel BTK inhibitor evobrutinib (M2951) in healthy volunteers
NobleIDNI2P77W82R89S62
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/773D2DBD)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims